Australia markets closed

Beijing Tong Ren Tang Chinese Medicine Company Limited (TQR.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
1.1900-0.0100 (-0.83%)
At close: 08:03AM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 1.02B
Enterprise value 759.66M
Trailing P/E 15.70
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.60
Price/book (mrq)2.21
Enterprise value/revenue 4.24
Enterprise value/EBITDA 8.32

Trading information

Stock price history

Beta (5Y monthly) 0.38
52-week change 3-35.48%
S&P500 52-week change 326.49%
52-week high 31.8700
52-week low 31.0300
50-day moving average 31.0964
200-day moving average 31.3262

Share statistics

Avg vol (3-month) 369
Avg vol (10-day) 3N/A
Shares outstanding 5837.1M
Implied shares outstanding 6853.26M
Float 8236.31M
% held by insiders 171.77%
% held by institutions 15.60%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.04
Forward annual dividend yield 43.21%
Trailing annual dividend rate 30.33
Trailing annual dividend yield 327.50%
5-year average dividend yield 42.41
Payout ratio 450.77%
Dividend date 3N/A
Ex-dividend date 404 June 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in HKD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 35.44%
Operating margin (ttm)41.04%

Management effectiveness

Return on assets (ttm)8.98%
Return on equity (ttm)15.22%

Income statement

Revenue (ttm)1.52B
Revenue per share (ttm)1.82
Quarterly revenue growth (yoy)-35.50%
Gross profit (ttm)N/A
EBITDA 638.96M
Net income avi to common (ttm)540.39M
Diluted EPS (ttm)0.0800
Quarterly earnings growth (yoy)-36.40%

Balance sheet

Total cash (mrq)2.4B
Total cash per share (mrq)2.87
Total debt (mrq)131.81M
Total debt/equity (mrq)3.28%
Current ratio (mrq)11.65
Book value per share (mrq)4.62

Cash flow statement

Operating cash flow (ttm)460.83M
Levered free cash flow (ttm)317.64M